Click here to get full coverage on Alkem launches Renocia Exo, Ginsenoside Exosome-based hair growth serum - expresspharma.in

Alkem launches Renocia Exo, Ginsenoside Exosome-based hair growth serum  expresspharma.in

Alkem launches Renocia Exo, Ginsenoside Exosome-based hair growth serum - expresspharma.in

Click here to get full coverage on Alkem launches India’s first patented Ginsenoside Exosome hair growth Serum, Renocia Exo - Indian Pharma Post

Alkem launches India’s first patented Ginsenoside Exosome hair growth Serum, Renocia Exo  Indian Pharma Post

Alkem launches India’s first patented Ginsenoside Exosome hair growth Serum, Renocia Exo - Indian Pharma Post

Click here to get full coverage on Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside - finance.yahoo.com

Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside  finance.yahoo.com

Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside - finance.yahoo.com

Click here to get full coverage on Pfizer Drops Patent Suit Over Alkem Copies of Inlyta Cancer Drug - Bloomberg Law News

Pfizer Drops Patent Suit Over Alkem Copies of Inlyta Cancer Drug  Bloomberg Law News

Pfizer Drops Patent Suit Over Alkem Copies of Inlyta Cancer Drug - Bloomberg Law News

Click here to get full coverage on Alkem launches India’s first patented ginsenoside exosome-based hair growth serum - CNBC TV18

Alkem launches India’s first patented ginsenoside exosome-based hair growth serum  CNBC TV18

Alkem launches India’s first patented ginsenoside exosome-based hair growth serum - CNBC TV18

Click here to get full coverage on Alkem Laboratories: Receives 7 Observations In US FDA Form 483 After Inspection Of Daman Facility - scanx.trade

Alkem Laboratories: Receives 7 Observations In US FDA Form 483 After Inspection Of Daman Facility  scanx.trade

Alkem Laboratories: Receives 7 Observations In US FDA Form 483 After Inspection Of Daman Facility - scanx.trade

Click here to get full coverage on Alkem Laboratories Launches India's First Patented Ginsenoside Exosome Hair Growth Serum - Sahi

Alkem Laboratories Launches India's First Patented Ginsenoside Exosome Hair Growth Serum  Sahi

Alkem Laboratories Launches India's First Patented Ginsenoside Exosome Hair Growth Serum - Sahi

Click here to get full coverage on Occlutech to gain Alkem as majority shareholder - Startupticker.ch

Occlutech to gain Alkem as majority shareholder  Startupticker.ch

Occlutech to gain Alkem as majority shareholder - Startupticker.ch

Click here to get full coverage on Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth - NDTV Profit

Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth  NDTV Profit

Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth - NDTV Profit

Click here to get full coverage on Alkem Laboratories 1QFY27: Nomura retains 'Buy' despite earnings miss - TradingView

Alkem Laboratories 1QFY27: Nomura retains 'Buy' despite earnings miss  TradingView

Alkem Laboratories 1QFY27: Nomura retains 'Buy' despite earnings miss - TradingView

Click here to get full coverage on AbbVie Seeks Block On Alkem Generic Constipation Drug - Law360

AbbVie Seeks Block On Alkem Generic Constipation Drug  Law360

AbbVie Seeks Block On Alkem Generic Constipation Drug - Law360

Click here to get full coverage on Alkem funds ₹1,100 crore subsidiary deal to buy control of Occlutech - Dealroom

Alkem funds ₹1,100 crore subsidiary deal to buy control of Occlutech  Dealroom

Alkem funds ₹1,100 crore subsidiary deal to buy control of Occlutech - Dealroom

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug - Bloomberg Law News

Click here to get full coverage on Alkem Laboratories launches Renocia Exo hair growth serum - scanx.trade

Alkem Laboratories launches Renocia Exo hair growth serum  scanx.trade

Alkem Laboratories launches Renocia Exo hair growth serum - scanx.trade

Click here to get full coverage on India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million - Yahoo Finance Singapore

India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million  Yahoo Finance Singapore

India's Alkem Labs unit to buy up to 55% of Occlutech for $118 million - Yahoo Finance Singapore

Click here to get full coverage on Alkem Labs Acquires Rights Shares Aggregating To 11 Billion Rupees Offered By Alkem Medtech - TradingView

Alkem Labs Acquires Rights Shares Aggregating To 11 Billion Rupees Offered By Alkem Medtech  TradingView

Alkem Labs Acquires Rights Shares Aggregating To 11 Billion Rupees Offered By Alkem Medtech - TradingView

Click here to get full coverage on Alkem Labs Gets Target Price Hike After Q1 Beat, But Motilal Oswal Stays Neutral — Here's Why - NDTV Profit

Alkem Labs Gets Target Price Hike After Q1 Beat, But Motilal Oswal Stays Neutral — Here's Why  NDTV Profit

Alkem Labs Gets Target Price Hike After Q1 Beat, But Motilal Oswal Stays Neutral — Here's Why - NDTV Profit

Click here to get full coverage on Alkem Labs shares fall nearly 5% after CEO resignation announcement - TradingView

Alkem Labs shares fall nearly 5% after CEO resignation announcement  TradingView

Alkem Labs shares fall nearly 5% after CEO resignation announcement - TradingView

Click here to get full coverage on Alkem Laboratories Ltd. Revenue Breakdown – NSE:ALKEM - TradingView

Alkem Laboratories Ltd. Revenue Breakdown – NSE:ALKEM  TradingView

Alkem Laboratories Ltd. Revenue Breakdown – NSE:ALKEM - TradingView

Click here to get full coverage on Alkem Laboratories Receives Favourable GST Order-in-Appeal, Demand of Rs. 69,65,52,636/- Dropped - scanx.trade

Alkem Laboratories Receives Favourable GST Order-in-Appeal, Demand of Rs. 69,65,52,636/- Dropped  scanx.trade

Alkem Laboratories Receives Favourable GST Order-in-Appeal, Demand of Rs. 69,65,52,636/- Dropped - scanx.trade

Click here to get full coverage on Alkem Labs' Daman Facility Gets 7 USFDA Observations, Classified as OAI - Medical Dialogues

Alkem Labs' Daman Facility Gets 7 USFDA Observations, Classified as OAI  Medical Dialogues

Alkem Labs' Daman Facility Gets 7 USFDA Observations, Classified as OAI - Medical Dialogues

Click here to get full coverage on ALKEM Forecast — Price Target — Prediction for 2027 - TradingView

ALKEM Forecast — Price Target — Prediction for 2027  TradingView

ALKEM Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Alkem Laboratories Limited (NSE:ALKEM) Just Released Its First-Quarter Earnings: Here's What Analysts Think - simplywall.st

Alkem Laboratories Limited (NSE:ALKEM) Just Released Its First-Quarter Earnings: Here's What Analysts Think  simplywall.st

Alkem Laboratories Limited (NSE:ALKEM) Just Released Its First-Quarter Earnings: Here's What Analysts Think - simplywall.st

Click here to get full coverage on Promoters sell Rs 930 crore worth Alkem Labs shares to domestic, global investors - TradingView

Promoters sell Rs 930 crore worth Alkem Labs shares to domestic, global investors  TradingView

Promoters sell Rs 930 crore worth Alkem Labs shares to domestic, global investors - TradingView

Click here to get full coverage on Alkem launches pre-filled syringe of Semaglutide at ₹350 starting price - pharma.economictimes.indiatimes.com

Alkem launches pre-filled syringe of Semaglutide at ₹350 starting price  pharma.economictimes.indiatimes.com

Alkem launches pre-filled syringe of Semaglutide at ₹350 starting price - pharma.economictimes.indiatimes.com

Click here to get full coverage on Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore - TradingView

Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore  TradingView

Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore - TradingView

Click here to get full coverage on Alkem Labs CEO Vikas Gupta may exit company - The Economic Times

Alkem Labs CEO Vikas Gupta may exit company  The Economic Times

Alkem Labs CEO Vikas Gupta may exit company - The Economic Times

Click here to get full coverage on Alkem Laboratories Limited (NSE:ALKEM) Looks Interesting, And It's About To Pay A Dividend - simplywall.st

Alkem Laboratories Limited (NSE:ALKEM) Looks Interesting, And It's About To Pay A Dividend  simplywall.st

Alkem Laboratories Limited (NSE:ALKEM) Looks Interesting, And It's About To Pay A Dividend - simplywall.st

Click here to get full coverage on Alkem Laboratories’ Daman facility gets US FDA OAI classification after seven observations - CNBC TV18

Alkem Laboratories’ Daman facility gets US FDA OAI classification after seven observations  CNBC TV18

Alkem Laboratories’ Daman facility gets US FDA OAI classification after seven observations - CNBC TV18

Click here to get full coverage on ALKEM: FY26 saw robust revenue and profit growth, with a final dividend of ₹10 per share recommended - TradingView

ALKEM: FY26 saw robust revenue and profit growth, with a final dividend of ₹10 per share recommended  TradingView

ALKEM: FY26 saw robust revenue and profit growth, with a final dividend of ₹10 per share recommended - TradingView

Click here to get full coverage on Alkem Laboratories wins tax appeal; ₹661 crore disallowance scrapped - legal.economictimes.indiatimes.com

Alkem Laboratories wins tax appeal; ₹661 crore disallowance scrapped  legal.economictimes.indiatimes.com

Alkem Laboratories wins tax appeal; ₹661 crore disallowance scrapped - legal.economictimes.indiatimes.com

Click here to get full coverage on Alkem takes majority stake in Swiss medtech firm Occlutech - Dealroom

Alkem takes majority stake in Swiss medtech firm Occlutech  Dealroom

Alkem takes majority stake in Swiss medtech firm Occlutech - Dealroom

Click here to get full coverage on Alkem Labs CEO Vikas Gupta Exits Company - NDTV Profit

Alkem Labs CEO Vikas Gupta Exits Company  NDTV Profit

Alkem Labs CEO Vikas Gupta Exits Company - NDTV Profit

Click here to get full coverage on Alkem Laboratories Shares Rise 2% in Today's Session - Moneycontrol.com

Alkem Laboratories Shares Rise 2% in Today's Session  Moneycontrol.com

Alkem Laboratories Shares Rise 2% in Today's Session - Moneycontrol.com

Click here to get full coverage on Alkem Labs Q1 Results: Shares down 3% after profit falls; revenue rises 11% - CNBC TV18

Alkem Labs Q1 Results: Shares down 3% after profit falls; revenue rises 11%  CNBC TV18

Alkem Labs Q1 Results: Shares down 3% after profit falls; revenue rises 11% - CNBC TV18

Click here to get full coverage on Buy Alkem Laboratories; target of Rs 6850: ICICI Securities - TradingView

Buy Alkem Laboratories; target of Rs 6850: ICICI Securities  TradingView

Buy Alkem Laboratories; target of Rs 6850: ICICI Securities - TradingView

Click here to get full coverage on Dr. Vikas Gupta, Alkem Laboratories - Investment Reports

Dr. Vikas Gupta, Alkem Laboratories  Investment Reports

Dr. Vikas Gupta, Alkem Laboratories - Investment Reports

Click here to get full coverage on Alkem Laboratories Q2 Results FY27: Date, Expectations - Univest

Alkem Laboratories Q2 Results FY27: Date, Expectations  Univest

Alkem Laboratories Q2 Results FY27: Date, Expectations - Univest

Click here to get full coverage on India Gets First Semaglutide Single-shot Syringe As Alkem Expands Access - BW Healthcare World

India Gets First Semaglutide Single-shot Syringe As Alkem Expands Access  BW Healthcare World

India Gets First Semaglutide Single-shot Syringe As Alkem Expands Access - BW Healthcare World

Click here to get full coverage on Ascend Laboratories names Ashish Mallela head of Americas business - Chain Drug Review

Ascend Laboratories names Ashish Mallela head of Americas business  Chain Drug Review

Ascend Laboratories names Ashish Mallela head of Americas business - Chain Drug Review

Click here to get full coverage on Alkem Labs net profit tanks 22% to ₹236 crore in Q4 FY26 - pharma.economictimes.indiatimes.com

Alkem Labs net profit tanks 22% to ₹236 crore in Q4 FY26  pharma.economictimes.indiatimes.com

Alkem Labs net profit tanks 22% to ₹236 crore in Q4 FY26 - pharma.economictimes.indiatimes.com

Click here to get full coverage on Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley am - The Economic Times

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley am  The Economic Times

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley am - The Economic Times

Click here to get full coverage on ChrysCapital completes Novartis India Limited buy, taps former Alkem executive Vikas Gupta as CEO - Moneycontrol.com

ChrysCapital completes Novartis India Limited buy, taps former Alkem executive Vikas Gupta as CEO  Moneycontrol.com

ChrysCapital completes Novartis India Limited buy, taps former Alkem executive Vikas Gupta as CEO - Moneycontrol.com

Click here to get full coverage on Five reasons behind Investec's upgrade of Alkem Labs, and why JPMorgan is cautious - CNBC TV18

Five reasons behind Investec's upgrade of Alkem Labs, and why JPMorgan is cautious  CNBC TV18

Five reasons behind Investec's upgrade of Alkem Labs, and why JPMorgan is cautious - CNBC TV18

Click here to get full coverage on Broker’s Call: Alkem Laboratories (Buy) - BusinessLine

Broker’s Call: Alkem Laboratories (Buy)  BusinessLine

Broker’s Call: Alkem Laboratories (Buy) - BusinessLine

Click here to get full coverage on Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem - Pearce IP

Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem  Pearce IP

Amgen Commences 11th BPCIA Denosumab Litigation Against Alkem - Pearce IP

Click here to get full coverage on Alkem Laboratories shareholders approve Adroit Biomed merger scheme - scanx.trade

Alkem Laboratories shareholders approve Adroit Biomed merger scheme  scanx.trade

Alkem Laboratories shareholders approve Adroit Biomed merger scheme - scanx.trade

Click here to get full coverage on Alkem Labs stock jumps after Q4 revenue growth and upbeat FY27 outlook - BusinessLine

Alkem Labs stock jumps after Q4 revenue growth and upbeat FY27 outlook  BusinessLine

Alkem Labs stock jumps after Q4 revenue growth and upbeat FY27 outlook - BusinessLine

Click here to get full coverage on Stocks to Watch Today: Alkem Labs, J Kumar Infra, Dabur, Britannia, Siemens Energy, Shipping Corporation,... - Moneycontrol.com

Stocks to Watch Today: Alkem Labs, J Kumar Infra, Dabur, Britannia, Siemens Energy, Shipping Corporation,...  Moneycontrol.com

Stocks to Watch Today: Alkem Labs, J Kumar Infra, Dabur, Britannia, Siemens Energy, Shipping Corporation,... - Moneycontrol.com

Click here to get full coverage on Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss - The Economic Times

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss  The Economic Times

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss - The Economic Times

Click here to get full coverage on Alkem Laboratories launches semaglutide in India at ₹450 per week, eyes booming weight-loss market - ET Manufacturing

Alkem Laboratories launches semaglutide in India at ₹450 per week, eyes booming weight-loss market  ET Manufacturing

Alkem Laboratories launches semaglutide in India at ₹450 per week, eyes booming weight-loss market - ET Manufacturing

Click here to get full coverage on Alkem Laboratories Shares Fall Over 2% Amidst Bearish Sentiment - Moneycontrol.com

Alkem Laboratories Shares Fall Over 2% Amidst Bearish Sentiment  Moneycontrol.com

Alkem Laboratories Shares Fall Over 2% Amidst Bearish Sentiment - Moneycontrol.com

Click here to get full coverage on Obesity bet may drive focus on chronic segment: Alkem Labs - The Economic Times

Obesity bet may drive focus on chronic segment: Alkem Labs  The Economic Times

Obesity bet may drive focus on chronic segment: Alkem Labs - The Economic Times

Click here to get full coverage on Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up - simplywall.st

Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up  simplywall.st

Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up - simplywall.st

Click here to get full coverage on Alkem Labs: Promoters Sell Stake for Rs 930 Crore - Rediff MoneyWiz

Alkem Labs: Promoters Sell Stake for Rs 930 Crore  Rediff MoneyWiz

Alkem Labs: Promoters Sell Stake for Rs 930 Crore - Rediff MoneyWiz

Click here to get full coverage on Alkem completes acquisition of majority stake in Switzerland's Occlutech - Indian Pharma Post

Alkem completes acquisition of majority stake in Switzerland's Occlutech  Indian Pharma Post

Alkem completes acquisition of majority stake in Switzerland's Occlutech - Indian Pharma Post

Click here to get full coverage on Alkem Lab’s core profit jumps 41% in Q4 on strong domestic, global growth - Moneycontrol.com

Alkem Lab’s core profit jumps 41% in Q4 on strong domestic, global growth  Moneycontrol.com

Alkem Lab’s core profit jumps 41% in Q4 on strong domestic, global growth - Moneycontrol.com

Click here to get full coverage on Neutral ALKEM Laboratories; target of Rs 5770: Motilal Oswal - Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5770: Motilal Oswal  Moneycontrol.com

Neutral ALKEM Laboratories; target of Rs 5770: Motilal Oswal - Moneycontrol.com

Click here to get full coverage on Alkem rolls out 80% cheaper variant of semaglutide in India - pharma.economictimes.indiatimes.com

Alkem rolls out 80% cheaper variant of semaglutide in India  pharma.economictimes.indiatimes.com

Alkem rolls out 80% cheaper variant of semaglutide in India - pharma.economictimes.indiatimes.com

Click here to get full coverage on Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal - The Economic Times

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal  The Economic Times

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal - The Economic Times

Click here to get full coverage on Income Tax Dept imposes INR 338.3 cr fine on Alkem Laboratories - legal.economictimes.indiatimes.com

Income Tax Dept imposes INR 338.3 cr fine on Alkem Laboratories  legal.economictimes.indiatimes.com

Income Tax Dept imposes INR 338.3 cr fine on Alkem Laboratories - legal.economictimes.indiatimes.com

Click here to get full coverage on Alkem Laboratories Ltd. Key Financial Ratios – Valuation, Profitability & More - Value Research

Alkem Laboratories Ltd. Key Financial Ratios – Valuation, Profitability & More  Value Research

Alkem Laboratories Ltd. Key Financial Ratios – Valuation, Profitability & More - Value Research

Click here to get full coverage on Alkem MedTech to acquire 55% stake in Occlutech for €99.4 million - Business Standard

Alkem MedTech to acquire 55% stake in Occlutech for €99.4 million  Business Standard

Alkem MedTech to acquire 55% stake in Occlutech for €99.4 million - Business Standard

Click here to get full coverage on Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit - NDTV Profit

Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit  NDTV Profit

Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit - NDTV Profit

Click here to get full coverage on Alkem rolls out single-shot pre-filled syringes of semaglutide - BusinessLine

Alkem rolls out single-shot pre-filled syringes of semaglutide  BusinessLine

Alkem rolls out single-shot pre-filled syringes of semaglutide - BusinessLine

Click here to get full coverage on Glenmark Pharmaceuticals Appoints Priyanka Tewari As Head Of Marketing - BW Marketing World

Glenmark Pharmaceuticals Appoints Priyanka Tewari As Head Of Marketing  BW Marketing World

Glenmark Pharmaceuticals Appoints Priyanka Tewari As Head Of Marketing - BW Marketing World

Click here to get full coverage on Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets - The Economic Times

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets  The Economic Times

ALKEM

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Alkem launches Renocia Exo, Ginsenoside Exosome-based hair growth serum - expresspharma.in

Alkem launches India’s first patented Ginsenoside Exosome hair growth Serum, Renocia Exo - Indian Pharma Post

Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside - finance.yahoo.com

Advanced Charts

Top Gainers

Top Losers